CORC  > 吉林大学白求恩第一医院
Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs
Ye, Shandong; Liu, Jun; Yang, Wenying; Miao, Heng; Ersoy, Canan; Asirvatham, Arthur; Werther, Shanti; Kadu, Priti; Chow, Francis; Wang, Guixia
刊名DIABETES RESEARCH AND CLINICAL PRACTICE
2019
卷号150
关键词Type 2 diabetes mellitus Primary care Insulin Premixed
ISSN号0168-8227
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3534252
专题吉林大学白求恩第一医院
推荐引用方式
GB/T 7714
Ye, Shandong,Liu, Jun,Yang, Wenying,et al. Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs[J]. DIABETES RESEARCH AND CLINICAL PRACTICE,2019,150.
APA Ye, Shandong.,Liu, Jun.,Yang, Wenying.,Miao, Heng.,Ersoy, Canan.,...&Wang, Guixia.(2019).Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs.DIABETES RESEARCH AND CLINICAL PRACTICE,150.
MLA Ye, Shandong,et al."Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs".DIABETES RESEARCH AND CLINICAL PRACTICE 150(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace